The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiopharma Cred. Share News (BPCR)

Share Price Information for Biopharma Cred. (BPCR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.878
Bid: 0.00
Ask: 0.92
Change: 0.00 (0.00%)
Spread: 0.042 (4.784%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 0.878
BPCR Live PriceLast checked at -
BioPharma Credit is an Investment Trust

To generate long-term shareholder returns, predominantly in the form of sustainable income distributions from exposure to the life sciences industry.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Anglo Asian to restart Gedabek operations on approval

Tue, 26th Sep 2023 21:47

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

Anglo Asian Mining PLC - Copper, gold and silver producer focused on Azerbaijan - Says the final Micon report was delivered on Tuesday to the company and the Government of Azerbaijan. Following the receipt of the report, the Prime Minister of Azerbaijan issued a press release saying that based on the report, the Gedabek plant can gradually restart operations. The restart of operations will take place in accordance with a timetable to be agreed with the Government. Anglo Asian and the government will also work together to implement Micon's recommendations for the Gedabek operation contained in the report.

----------

BSF Enterprise PLC - London-based biotechnology investor - Confirms allotment of 364,739 ordinary shares, constituting the 264,739 second tranche shares and the 100,000 financial PR shares, conditional to trading on the London Stock Exchange's Main Market at an issue price of 17 pence per share. Expects that admission will become effective on Wednesday.

----------

Power Metal Resources PLC - Metals exploration company focused on North America, Africa, and Australia - Hails escalation of high priority uranium target, based on a remote sensing study at its Badger Lake uranium project located in the Athabasca Basin, Saskatchewan, Canada. Says analysis finds distinct similarities between Badger Lake and the Arrow Deposit, owned and operated by Nexgen Energy Ltd. Plans to expedite the planned high-resolution electromagnetic UAV survey over Badger Lake, and reemphasises that the target at Badger Lake is an "extremely attractive exploration target". Chief Executive Officer Sean Wade says: "These findings could not come at a better time for shareholders and serve to highlight the huge potential value inherent in our uranium portfolio and in the Power Metal business model more generally."

----------

Ediston Property Investment Co PLC - London-based real estate investment trust focused on UK commercial property - Says shareholders have approved the sale of EPIC Group's property portfolio to RI UK 1 Ltd, a wholly owned subsidiary of Realty Income, for GBP200.8 million. This is prior to agreed deductions of approximately GBP4.0 million.

----------

Amte Power PLC - London-based lithium-ion and sodium-ion battery cells developer and manufacturer - Says shares were restored to trading on Tuesday in London at 1330 BST. Follows announcement on Monday that Amte would make an announcement regarding the launch of a retail offer following the lifting of the suspension of trading.

----------

Grafenia PLC - Manchester-based printing and software company - Says it will formally change its name to Software Circle PLC "in the coming days", as the relevant paperwork has been filed with Companies House. Adds that a further announcement will be made when the name change is formally effective. Upon the change of name becoming effective, the company's TIDM will change from "GRA" to "SFT". The ISIN and SEDOL numbers will remain unchanged.

----------

Croda International PLC - Yorkshire, England-based chemicals firm - Says Nicholas Ian Challoner, a member of the executive committee, sells 6,339 shares in the company at GBP49.16 each, coming to a total of GBP311,617 in shares.

----------

BioPharma Credit PLC - Specialist life sciences debt investment trust - Notes filing by LumiraDx Ltd, which discloses an amendment to the loan agreement entered into with BioPharma Credit PLC, BPCR Ltd Partnership, and BioPharma Credit Investments V LP. On September 25, LumiraDx entered into a twelfth amendment and waiver to the loan agreement of March 31. This amendment made several stipulations, including that the minimum liquidity covenant in the agreement is waived until October 11, provided that the consolidated liquidity of the company and its subsidiaries during this waiver period must be at least USD5 million, that the minimum net sales covenant for the trailing twelve-month period ended June 30 is waived. BioPharma Credit expects that the USD3.0 million Tranche D loan amount will be funded on Wednesday.

----------

ActiveOps PLC - Reading, England-based management process automation software provider for back-office operations - Launches ControliQ Series 3, a new version of its management process automation product. Says that ControliQ Series 3 has additional artifical intelligence features. Following the official launch in August, customers across multiple geographies and sectors are already using the new capabilities. ActiveOps intends to launch the ControliQ Series 4 in 2024.

----------

By Holly Beveridge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
13 Dec 2019 16:20

Biopharma Credit Loans Sarepta Therapeutics USD450 Million

Biopharma Credit Loans Sarepta Therapeutics USD450 Million

Read more
13 Nov 2019 16:10

BioPharma Credit Invests In Biopharmaceutical Firms Epizyme And Akebia

BioPharma Credit Invests In Biopharmaceutical Firms Epizyme And Akebia

Read more
13 Nov 2019 10:36

BioPharma Credit pours cash into US firms Epizyme and Akebia

(Sharecast News) - Specialist life sciences debt investor BioPharma Credit has entered into two separate loan agreements, where it will invest $52.5m now and up to an additional $32.5m over the next 12 months, it announced on Wednesday.

Read more
13 Sep 2019 11:30

BioPharma Credit To Invest USD150 Million In OptiNose US

(Alliance News) - BioPharma Credit PLC on Friday said it, alongside subsidiary BioPharma Credit Investments V Master LP, has agreed to buy senior secured notes of OptiNose US Inc for up to USD150

Read more
11 Sep 2019 18:19

BioPharma Credit Says Lexicon-Sanofi Settlement Enhances Loan Assets

(Alliance News) - BioPharma Credit PLC said Wednesday the termination of an alliance between Sanofi SA and Lexicon Pharmaceuticals Inc enhances the collateral value behind its loan to - a debt - a

Read more
4 Sep 2019 12:50

BioPharma Credit Net Assets Rise On Tesaro Sale To GlaxoSmithKline

(Alliance News) - BioPharma Credit PLC on Wednesday reported a rise in net assets over the first half following the acquisition of a portfolio company by pharma giant GlaxoSmithKline PLC.At

Read more
2 Aug 2019 17:31

BioPharma Credit Declares Unchanged Second Quarter Dividend

(Alliance News) - Life science debt investor BioPharma Credit PLC declared a flat second quarter interim dividend.The USD0.02 per share dividend for the period ended June 30 is also flat is

Read more
30 Jul 2019 14:42

BioPharma Credit Notes Sanofi Termination Of Agreement With Lexicon

(Alliance News) - BioPharma Credit PLC on Tuesday noted the termination of Sanofi SA's collaboration and licence agreement with Lexicon Pharmaceuticals Inc over diabetes drug Credit, a life of

Read more
29 May 2019 09:34

BioPharma Credit Invests In Nasdaq-Listed Pharmaceutical Firm (ALLISS)

LONDON (Alliance News) - Life sciences debt investor BioPharma Credit PLC has advanced up to USD80 million to a US-based investee, and also bought some of the company's shares, it said has the

Read more
5 Mar 2019 15:14

BioPharma Credit Net Asset Value Per Share Holds After Two Placings

LONDON (Alliance News) - BioPharma Credit PLC on Tuesday said its net assets increased sharply in total in 2018 but two sizeable share placings meant that its net asset value per share was largely

Read more
22 Jan 2019 16:43

BioPharma Credit To Receive Tesaro Loan Payment After GSK Acquisition

LONDON (Alliance News) - BioPharma Credit PLC on Tuesday said it will now receive a USD370.0 million loan repayment as GlaxoSmithKline PLC has completed its Tesaro Inc acquisition.The Glaxo

Read more
6 Dec 2018 14:36

BioPharma Credit Appoints Stephanie Leouzon As Non-Executive Director

LONDON (Alliance News) - BioPharma Credit PLC said Thursday it appointed Stephanie Leouzon as non-executive director with immediate effect.Currently, Leouzon is a partner and head at She on

Read more
1 Nov 2018 11:32

BioPharma Placing Exceeds Upgraded Issue Size, Raises USD305 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC on Thursday said it raised USD305 million after its proposed placing exceeded its upgraded issue size.The pharmaceutical focused investment at

Read more
26 Oct 2018 10:56

BioPharma Credit C Shares Suspended From Trading Pending Announcement (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC's C shares were temporarily suspended from trading on the specialist fund segment of the London Stock Exchange pending an announcement by the in

Read more
24 Oct 2018 11:33

BioPharma Credit Increases Placing Size To USD200 Million (ALLISS)

LONDON (Alliance News) - BioPharma Credit PLC said Wednesday it increased the size of its proposed placing to "at least" USD200 million due to strong investor demand.Last Friday,

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.